AKAM
37
-2
MMC
37
-3
HOG
29
2
SLG
32
-2
XEL
50
-3
MAC
53
5
FITB
30
2
FLS
60
5
CAG
53
12
EIX
58
-3
EXC
64
4
VFC
50
-4
AES
49
3
PRU
45
5
DAL
50
3
VIX
46
-15
PCG
74
8
JPM
57
5
WMT
66
2
CTAS
39
3
AKAM
37
-2
MMC
37
-3
HOG
29
2
SLG
32
-2
XEL
50
-3
MAC
53
5
FITB
30
2
FLS
60
5
CAG
53
12
EIX
58
-3
EXC
64
4
VFC
50
-4
AES
49
3
PRU
45
5
DAL
50
3
VIX
46
-15
PCG
74
8
JPM
57
5
WMT
66
2
CTAS
39
3
Financhill
Back

Immunocore Holdings PLC 10K Form

Sell
20

IMCR
Immunocore Holdings PLC

Last Price:
$29.87
Seasonality Move:
-10.17%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IMCR News And Ratings

See the #1 stock for the next 7 days that we like better than IMCR

IMCR Financial Statistics

Sales & Book Value

Annual Sales: $249.4M
Cash Flow: $20.3M
Price / Cash Flow: 75.97
Annual Sales: $7.55
Price / Book: 3.95

Profitability

EPS (TTM): -0.95000
Net Income (TTM): $-47M
Gross Margin: $248.4M
Return on Equity: -12.92%
Return on Assets: -5.52%

Immunocore Holdings PLC Earnings Forecast

Key Immunocore Holdings PLC Financial Ratios

  • The Gross Profit Margin over the past 4 years for IMCR is 99.58%.
  • The Selling, General & Administrative Expenses for IMCR have been equal to 57.93% of Gross Profit Margin.
  • The Research & Development expenses have been 65.57% of Revenue.
  • The Interest Expense is -9.32% of Operating Income.
  • The Net Earning history of IMCR is -22.17% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 2 years.

Immunocore Holdings PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: IMCR
Website: immunocore.com

Debt

Debt-to-Equity Ratio: 1.16
Current Ratio: 3.78
Quick Ratio: 3.62

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IMCR Technical Analysis vs Fundamental Analysis

Sell
20
Immunocore Holdings PLC (IMCR) is a Sell

Is Immunocore Holdings PLC a Buy or a Sell?